What Additional Special Measures May Be Needed In The Context Of COVID-19?
In addition to routine approaches to malaria control, there may be a case for special measures in the context of the COVID-19 pandemic – such as a temporary return to presumptive malaria treatment, or the use of mass drug administration – which have proved useful in some previous emergencies.
Presumptive malaria treatment refers to treatment of a suspected malaria case without the benefit of diagnostic confirmation (e.g. through a rapid diagnostic test). This approach is typically reserved for extreme circumstances, such as disease in settings where prompt diagnosis is no longer possible.
Mass drug administration (MDA) is a WHO-recommended approach for rapidly reducing malaria mortality and morbidity during epidemics and in complex emergency settings. Through MDA, all individuals in a targeted population are given antimalarial medicines – often at repeated intervals – regardless of whether or not they show symptoms of the disease.
Such special measures should only be adopted after careful consideration of 2 key aims: lowering malaria-related mortality and keeping health workers and communities safe. WHO is exploring concrete proposals for when and how to activate such measures; guidance will be published in due course.
What Additional Special Measures May Be Needed In The Context Of COVID-19?
Entrepreneurship has taken a leading role in fighting COVID-19.Collaboration and cooperation are proving to be key in this effort.We should take this opportuni
Remdesivir is an antiviral that is given by intravenous (IV) infusion in the hospital. This is a brand-new drug that has not been approved by the FDA for use o
Fusogenix DNA vaccine by Entos PharmaceuticalsEntos Pharmaceuticals is developing Fusogenix DNA vaccine developed using the Fusogenix drug delivery platform to